Matthew Churchill is a Neurology physician. OpenAlex indexes 5 publications with 342 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3020 Hamaker Ct
Suite 400
Fairfax, VA 220312238
Telephone
703-876-0800Provider last certified this registry record 8 Jun 2022.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20259 payments
- Lundbeck LLCProgram year20252 payments
- Life Molecular Imaging LtdProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
89.5%Neuromuscular Blocker89.1%Onabotulinumtoxina100%Part B, office-administered≥18 patientsMuscle Relaxant0.2%Cyclobenzaprine Hcl100%Part D≥11 patients+ 1 more class in this area
Nervous system
9.8%Cholinesterase Inhibitor2.7%Donepezil Hcl91%Galantamine Er6%Rivastigmine3%Part D<11 patientsN-methyl-D-aspartate Receptor Antagonist1.2%Memantine Hcl65%Memantine Hcl Er35%Part D≥27 patients+ 13 more classes in this area
Cardiovascular
0.4%Beta blocker0.4%Propranolol Hcl75%Propranolol Hcl Er26%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Inhibition of Intestinal Tumors by Curcumin Is Associated with Changes in the Intestinal Immune Cell Profile
Journal of Surgical Research
2000 - Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac.
PubMed
1999
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”